What's happened
Kris Hallenga, the founder of CoppaFeel! breast cancer awareness charity, passed away at 38 after a 15-year battle with terminal breast cancer. Diagnosed at 23, she dedicated her life to educating young people about early detection through her nonprofit organization.
Why it matters
Kris Hallenga's death at 38 marks the loss of a passionate advocate for breast cancer awareness. Her tireless efforts through CoppaFeel! have impacted millions, emphasizing the importance of early detection and challenging misconceptions about the disease. Her legacy will continue to inspire and educate future generations on the significance of proactive health measures.
What the papers say
The Guardian highlights Kris Hallenga's journey from diagnosis to founding CoppaFeel! and her impactful advocacy for breast cancer awareness. The New York Times reflects on Hallenga's determination to educate young people about early detection through her charity. The Independent emphasizes Hallenga's mission to raise awareness about breast cancer in young individuals and her efforts to expand the CoppaFeel! campaign nationwide.
How we got here
Kris Hallenga was diagnosed with stage 4 breast cancer at 23, leading her to establish CoppaFeel! in 2009 with her twin sister. Frustrated by the lack of information available for young people about breast cancer, Hallenga aimed to challenge stereotypes and promote proactive health practices. Her innovative approach, including projecting messages on landmarks and billboards, revolutionized cancer awareness campaigns.
Common question
More on these topics
-
CoppaFeel! is a breast cancer awareness charity, based in London. The charity focuses on promoting early detection of breast cancer by encouraging women under 30 to regularly check their breasts.
CoppaFeel! is a charity partner of Cosmopolitan magazine.
-
Kristin Hallenga is a Sun columnist and founder of breast cancer awareness charity CoppaFeel!. She received public attention after being profiled in Kris: Dying to Live, a documentary that covered her experience when she had terminal breast cancer.